Physician awareness of decompressive hemicraniectomy for malignant middle cerebral artery infarction in Saudi Arabia and the Gulf countries

References

1. ↵
   1. Vahedi K,
   2. Vicaut E,
   3. Mateo J,
   4. Kurtz A,
   5. Orabi M,
   6. Guichard JP,
   7. et al.

   (2007) Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke 38, 2506–2517.
2. ↵
   1. Neugebauer H,
   2. Creutzfeldt CJ,
   3. Hemphill JC 3rd.,
   4. Heuschmann PU,
   5. Jüttler E

   (2014) DESTINY-S: attitudes of physicians toward disability and treatment in malignant MCA infarction. Neurocrit Care 21, 27–34.
3. ↵
   1. Minnerup J,
   2. Wersching H,
   3. Ringelstein EB,
   4. Heindel W,
   5. Niederstadt T,
   6. Schilling M,
   7. et al.

   (2011) Prediction of malignant middle cerebral artery infarction using computed tomography-based intracranial volume reserve measurements. Stroke 42, 3403–3409.
4. ↵
   1. Hofmeijer J,
   2. Kappelle LJ,
   3. Algra A,
   4. Amelink GJ,
   5. van Gijn J,
   6. van der Worp HB,
   7. HAMLET investigators

   (2009) Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol 8, 326–333.
5. ↵
   1. Jüttler E,
   2. Schwab S,
   3. Schmiedek P,
   4. Unterberg A,
   5. Hennerici M,
   6. Woitzik J,
   7. et al.

   (2007) Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke 38, 2518–2525.